Latest Breaking News On - Rosetta capital - Page 3 : comparemela.com

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAliso viejoTorrey loperMarissa bychPeijia medicalQatar investment authorityBain capital life sciencesJenavalve technology incCompany trilogyValiance life sciencesPresented todayFindings demonstrate untreated mortality riskSome patientsModerate aortic regurgitationCardiac damageSevere aortic regurgitation

Sequana Medical announces 2023 Full Year Results and 2024 Outlook

PRESS RELEASE

Region flamandeUnited statesUnited kingdomPeter dhondtKenneth macleodCian crosbieCompany premarket approvalGood laboratory practiceDevice single audit programBritish standards institutionAmerican consortium for the study of endCompany or sequanaSequana medical us incAmerican medical associationSequana medicalEuronext brussels

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDennis riedlCompany or sequanamedicalCompany premarket approvalEuronext brusselsExecutive share optionKreos capitalBelgian actSequana medicalPremarket approvalNorth americanData safety monitoring boardKreos warrantsRosetta capital

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES EUR 3 0 MILLION CONVERTIBLE FINANCING FROM MAJOR SHAREHOLDERS AND AGREEMENT WITH LENDERS ON DEFERRAL OF DEBT SERVICE PAYMENTS

Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES EUR 3 0 MILLION CONVERTIBLE FINANCING FROM MAJOR SHAREHOLDERS AND AGREEMENT WITH LENDERS ON DEFERRAL OF DEBT SERVICE PAYMENTS
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSouth africaSouth australiaStefan klotterCian crosbieKenneth macleodCompany the committeeInternational financial reporting standardsEuropean unionCompany premarket approvalEuropean parliamentBlackrock incSwiss financial services act finCompany or sequanaAd hoc committee

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints

IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Val.

United kingdomUnited statesSan franciscoRaj makkarTorstenp vahlMarissa bychDuane pintoBain capital life sciencesVinod thourani piedmont heart institutePeijia medicalCompany trilogyQatar investment authorityValiance life sciencesJenavalve technology incDrug administrationValve technology